Lasa Supergenerics Limited

Healthcare · Pharmaceuticals & Biotechnology

BSE: 540702

₹5.67

Sept. 28, 2026 · BSE · bse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet. EBITDA = PBT + interest + depreciation.

Enterprise value

Data unavailable.

EV / EBITDA

Data unavailable.

EV / Sales

Data unavailable.

Market cap / Sales

Data unavailable.

Earnings yield

Data unavailable.

Quarterly Financials

Download CSV

Standalone Consolidated

↓ Negative

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 1 Cr, down 93.4% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	1	-3	—	₹0.7100
March 31, 2026	-0	-4	—	₹-0.8300
Dec. 31, 2025	2	-2	-3	₹-0.5100
Sept. 30, 2025	3	-6	-6	₹-1.2500
June 30, 2025	20	-23	—	₹-4.2200
March 31, 2025	39	-22	—	₹-2.8500
Dec. 31, 2024	33	6	5	₹1.1000
Sept. 30, 2024	39	-1	-3	₹0.6400
June 30, 2024	31	-2	-3	₹-0.5500
March 31, 2024	23	-16	-15	₹-3.0500
Dec. 31, 2023	27	-2	-1	₹-0.2900
Sept. 30, 2023	24	-2	-0	₹
June 30, 2023	31	1	-5	₹-0.9900

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	1	-0	2	3	20	42	33	41	31	23	27	24	31
Operating revenue	1	-0	2	3	20	39	33	39	31	23	27	24	31
Other income	0	0	0	0	0	2	0	2	0	0	0	0	0
Operating expenses	3	2	3	7	21	36	32	39	29	27	26	23	27
Operating profit	-1	-3	-1	-4	-1	3	1	1	2	-4	1	1	4
Operating profit margin	-113.4%	1956.0%	-34.0%	-130.6%	-2.5%	8.7%	2.4%	2.0%	5.8%	-17.5%	3.9%	4.3%	13.3%
Depreciation	2	1	2	2	2	4	3	3	3	3	3	3	3
Interest	0	0	0	0	0	0	0	1	1	1	0	1	0
Exceptional items, gain / (loss)	-0	—	—	—	-21	-24	8	—	—	-9	—	—	—
Profit before tax	-3	-4	-2	-6	-23	-22	6	-1	-2	-16	-2	-2	1
Tax	0	0	0	1	-1	-8	0	2	1	-1	-1	-2	6
Net profit	—	—	-3	-6	—	—	5	-3	-3	-15	-1	-0	-5
EPS	0.71	-0.83	-0.51	-1.25	-4.22	-2.85	1.10	0.64	-0.55	-3.05	-0.29	—	-0.99
Net profit (TTM)	—	—	—	—	—	—	-16	-23	-20	-22	-21	-25	—
EPS (TTM)	-1.88	-6.81	-8.83	-7.22	-5.33	-1.66	-1.86	-3.25	—	—	—	—	-6.81

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Total income (before exceptional items)	-42.2%	-34.0%	25^†	147^†	104^†	131^†	137^†	203^†	168^†	174^†
Operating revenue	-42.1%	-34.1%	25^†	142^†	104^†	130^†	137^†	202^†	167^†	170^†
Other income	—	—	0^†	4^†	0^†	2^†	0^†	0^†	1^†	4^†
Operating expenses	—	—	33^†	136^†	102^†	136^†	121^†	156^†	138^†	158^†
Operating profit	—	—	-8^†	7^†	2^†	-7^†	16^†	47^†	30^†	11^†
Operating profit margin	—	—	-31.1%^†	4.8%^†	2.1%^†	-5.1%^†	11.4%^†	23.0%^†	17.8%^†	6.6%^†
Depreciation	—	—	6^†	12^†	11^†	13^†	14^†	16^†	17^†	19^†
Interest	—	—	0^†	3^†	2^†	2^†	0^†	2^†	8^†	12^†
Exceptional items, gain / (loss)	—	—	-21^†	-16^†	-9^†	-22^†	-8^†	0^†	0^†	0^†
Profit before tax	—	—	-35^†	-19^†	-19^†	-42^†	-6^†	29^†	5^†	-16^†
Tax	—	—	-1^†	-5^†	3^†	-4^†	-1^†	8^†	1^†	-4^†
Net profit	—	—	—	—	-22^†	—	-5^†	—	—	—
EPS	—	—	-6.81^†	-1.66^†	—	-8.79^†	-1.32^†	5.59^†	1.11^†	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Operating margin	-31.1%^†	4.8%^†	2.1%^†	-5.1%^†	11.4%^†	23.0%^†	17.8%^†	6.6%^†
EBIT margin	-136.1%^†	-11.7%^†	-16.5%^†	-31.3%^†	-4.5%^†	15.3%^†	7.7%^†	-2.4%^†
PBT margin	-137.7%^†	-13.6%^†	-18.3%^†	-32.6%^†	-4.5%^†	14.6%^†	2.8%^†	-9.5%^†
Net margin	—	—	-20.8%^†	—	-3.9%^†	—	—	—
Interest coverage	-88.64x^†	-6.20x^†	-8.89x^†	-23.97x^†	-142.42x^†	19.87x^†	1.58x^†	-0.34x^†
Dividend payout	—	—	—	—	—	0.0%^†	0.0%^†	—
Earnings retention	—	—	—	—	—	100.0%^†	100.0%^†	—
Current ratio	0.62x	1.90x	—	—	—	—	—	—
Quick ratio	0.51x	0.47x	—	—	—	—	—	—
Debt to equity	0.20x	0.03x	—	—	—	—	—	—
Return on equity	—	—	—	—	—	—	—	—
Return on assets	—	—	—	—	—	—	—	—
Return on capital employed	-22.3%^†	-19.8%^†	—	—	—	—	—	—
Asset turnover	0.15x^†	1.40x^†	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	-23	0	0	0	-23
March 31, 2025	-3	8	-6	0	-3

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	170	50	-0	10	0	10	17	0	38	2
March 31, 2025	102	84	34	2	0	33	17	0	48	24

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.